Generation of B lymphoma cell lines from knockout mice by transformation in vivo with an Eμ-myc transgene

Journal of Immunological Methods

Volumn 228, Issue 1-2, 1999, Pages 131-138

  Corcoran, Lynn M ^a   Tawfilis, Sherif ^a   Barlow, Linda J ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

B cell lines; B220; E myc; lyn; OBF 1; oct 2; vav

Indexed keywords

ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL TRANSFORMATION; FEMALE; GENE MUTATION; IMMUNOPHENOTYPING; LYMPHOMA CELL LINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; FEMALE; GENES, MYC; IMMUNOLOGIC TECHNIQUES; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; TRANSFECTION; TRANSFORMATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032705226     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00094-0     Document Type: Article

References (26)

1. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 318:1985;533.
2. Alexander W.S., Bernard O., Cory S., Adams J.M. Lymphomagenesis in Eμ-myc transgenic mice can involve ras mutations. Oncogene. 4:1989;575.
3. Alt F., Rosenberg N., Lewis S., Thomas E., Baltimore D. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell. 27:1981;381.
4. Anderson P.N., Potter M. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature. 222:1969;9941.
5. Buerstedde J.M., Takeda S. Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell. 67(1):1991;179.
6. Chen Y.-W., Lin M.-S., Vora K.A. B cell differentiation: I. Development and functional analysis of murine B cells immortalized by a recombinant retrovirus. Int. Immunol. 4:1992;1293.
7. Cleveland J.L., Jansen H.W., Bister K., Fredrickson T.N., Morse H.C. III, Ihle J.N., Rapp U.R. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro. J. Biol. Chem. 30:1986;195.
8. Corcoran L.M., Karvelas M. Oct-2 is required in early T cell-independent B cell activation for G1 progression and for proliferation. Immunity. 1:1994;635.
9. Corcoran L.M., Karvelas M., Nossal G.J.V., Ye Z., Jacks T., Baltimore D. Oct-2, although not required for early B cell development, is critical for later B cell maturation and for postnatal survival. Genes Dev. 7:1993;570.
10. Harris A.W., Pinkert C.A., Crawford M., Langdon W.Y., Brinster R.L., Adams J.M. The Eμ-myc transgenic mouse: a model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167:1988;353.
11. Haupt Y., Alexander W.S., Barri G., Klinken S.P., Adams J.M. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice. Cell. 65:1991;753.
12. Hibbs M.L., Tarlinton D.M., Armes J., Grail D., Hodgson G., Maglitto R., Stacker S.A., Dunn A.R. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 83:1995;301.
13. Kantor A.B. V-gene usage and N-region insertions in B1-a, B1-b and conventional B cells. Semin. Immunol. 8:1996;29.
14. Kearney J.F., Bartels J., Hamilton A.M., Lehuen A., Solvason N., Vakil M. Development and function of the early B cell repertoire. Int. Rev. Immunol. 8:1992;247.
15. Potter M., Sklar M.D., Rowe W.P. Rapid viral induction of plasmacytomas in pristane-primed BALB/c mice. Science. 182:1973;592.
16. Rosenberg N., Baltimore D. A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J. Exp. Med. 143:1976;1453.
17. Rosenberg N., Baltimore D., Scher C.D. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 72:1975;1932.
18. Schlissel M.S., Baltimore D. Activation of immunoglobulin κ gene rearrangement correlates with induction of germline κ gene transcription. Cell. 58:1989;1001.
19. Schubart D.B., Rolink A., Kosco-Vilbois M.H., Botteri F., Matthias P. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature. 383:1996;538.
20. Serunian L.A., Rosenberg N. Abelson virus potentiates long-term growth of mature-B lymphocytes. Mol. Cell. Biol. 6:1986;183.
21. Strasser A., Harris A.W., Bath M.L., Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:1990;331-333.
22. Sugiyama H., Akira S., Yoshida N., Kishimoto S., Yamamura Y., Kincade P., Honjo T., Kishimoto T. Relationship between the rearrangement of immunoglobulin genes, the appearance of a B lymphocyte antigen, and immunoglobulin synthesis in murine pre-B cell lines. J. Immunol. 128:1982;2793.
23. Thomas J.D., Sideras P., Smith C., Vorechovsky I., Chapman V., Paul W.E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 261:1993;355.
24. Turner M., Lee P.J., Walters A.E., Quinn M.E., Mellor A.L., Zamoyska R., Tybulewicz V.L. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity. 7:1997;451.
25. Whitlock C.A., Ziegler S.F., Treiman L.J., Stafford J.I., Witte O.N. Differentiation of cloned populations of immature-B cells after transformation with Abelson murine leukemia virus. Cell. 32:1983;903.
26. Wu G.E., Atkinson M.J., Ramsden D.A., Paige C.J. VH gene repertoire. Semin. Immunol. 2:1990;207.